The patient perspective

Steve Schwarze, PALTOWN’s Director of Clinical Trials Programming and a stage IV CRC patient, gets into the details for you:

• the most important biomarkers CRC patients should know
• specific types of biomarker testing
• how precision medicine tools can provide new information to discuss with your care team
• some of the practical considerations for using these tools and working with your care team.